References
- Miller N. R. The optic nerve. Curr Opin Neurol 1996; 9: 5–15
- Singh R., Conway M. D., Wilson W. A. Antiphospholipid syndrome in a patient with sarcoidosis: a case report. Lupus 2002; 11: 756–8
- Marai I., Zandman‐Goddard G., Shoenfeld Y. The systemic nature of the antiphospholipid syndrome. Scand J Rheumatol 2004; 33: 365–72
- Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309–11
- Damoiseaux J., Wijffels M., Willems G. M., Bevers E. M., Spaanderman M. E., van Pampus E. C., et al. The antiphospholipid/cofactor syndrome: results of routine screening for antibodies to beta2‐GPI upon suspicion of the antiphospholipid syndrome. Scand J Rheumatol 2004; 33: 441–2
- Asherson R. A., Merry P., Acheson J. F., Harris E. N., Hughes G. R. V. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ‘primary’ antiphospholipid syndrome. Ann Rheum Dis 1989; 48: 358–61
- Castanon C., Amigo M. C., Banales J. L., Nava A., Reyes P. A. Ocular vaso‐occlusive disease in primary antiphospholipid syndrome. Ophthalmology 1995; 102: 256–62
- Champion B. L., Choy F., Schrieber L., Roche J., Rowe D. B. Isolated fascicular oculomotor nerve palsy as the initial presentation of the antiphospholipid syndrome. J Clin Neurosci 2002; 9: 691–4
- Cobo‐Soriano R., Sanchez‐Ramon S., Aparicio M. J., Teijeiro M. A., Vidal P., Suarez‐Leoz M., et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case–control study. Am J Ophthalmol 1999; 128: 725–32
- Gelfand Y. A., Dori D., Miller B., Brenner B. Visual disturbances and pathologic ocular findings in primary antiphospholipid syndrome. Ophthalmology 1999; 106: 1537–40